Century Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell IPSC and other ETFs, options, and stocks.About IPSC
Century Therapeutics, Inc. engages in the development of off-the-shelf cell therapies to advance the course of cancer care. It focuses on harnessing the power of adult stem cells to develop curative allogeneic cell therapies for cancer.
CEOBrent Pfeiffenberger
CEOBrent Pfeiffenberger
Employees150
Employees150
HeadquartersPhiladelphia, Pennsylvania
HeadquartersPhiladelphia, Pennsylvania
Founded2018
Founded2018
Employees150
Employees150
IPSC Key Statistics
Market cap54.74M
Market cap54.74M
Price-Earnings ratio-1.84
Price-Earnings ratio-1.84
Dividend yield—
Dividend yield—
Average volume818.23K
Average volume818.23K
High today$0.6397
High today$0.6397
Low today$0.5639
Low today$0.5639
Open price$0.572
Open price$0.572
Volume1.19M
Volume1.19M
52 Week high$1.26
52 Week high$1.26
52 Week low$0.3418
52 Week low$0.3418
Stock Snapshot
With a market cap of 54.74M, Century Therapeutics(IPSC) trades at $0.63. The stock has a price-to-earnings ratio of -1.84.
During the trading session on 2025-12-16, Century Therapeutics(IPSC) shares reached a daily high of $0.64 and a low of $0.56. At a current price of $0.63, the stock is +12.0% higher than the low and still -1.3% under the high.
Trading activity shows a volume of 1.19M, compared to an average daily volume of 818.23K.
The stock's 52-week range extends from a low of $0.34 to a high of $1.26.
The stock's 52-week range extends from a low of $0.34 to a high of $1.26.
People also own
Based on the portfolios of people who own IPSC. This list is generated using Robinhood data, and it’s not a recommendation.